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In contrast to human immunodeficiency viruses type 1 and type 2 (HIV-1 and HIV-2, respectively), simian immunodeficiency
virus (SIVmac) rarely uses CXCR4 (X4) for efficient entry into target cells. Basic amino acid residues in the V3 loop of HIV Env
allow efficient coreceptor utilization of X4. Therefore, we investigated if similar changes in the SIVmac Env protein also
mediate a coreceptor switch from CCR5 (R5) to X4. Functional analysis revealed that none of eight SIVmac variants,
containing V3 regions with an overall charge between 14 and 110, efficiently utilized X4 as entry cofactor. Nonetheless,
these alterations had differential effects on SIV coreceptor tropism and on Env expression levels. A single amino acid
substitution of L328R, located near the tip of the V3 loop, resulted in grossly reduced Env expression levels and impaired viral
infectivity. Notably, additional basic residues restored efficient Env expression and virion incorporation but not infectivity. In
comparison to the L328R mutation, changes of P334K and D337K had little disruptive effects on SIVmac entry and replication.
Interestingly, mutation of L320K and P321R disrupted coreceptor usage of GPR15 but not R5. These changes also impaired
SIVmac replication in peripheral blood mononuclear cells (PBMC) derived from a D32/D32 donor but not in R5-expressing
human or simian PBMC. Our results show that positively charged amino acid residues in the V3 loop affect SIVmac
coreceptor tropism and infectivity but do not allow efficient utilization of X4. © 2001 Academic PressINTRODUCTION
Primate lentiviruses enter target cells by binding the
external envelope glycoprotein (gp120) to the cellular
CD4 receptor and subsequent interactions with chemo-
kine receptors that mediate fusion between the viral and
host cell membrane (reviewed by Doms and Peiper,
1997; Moore et al., 1997; Bieniasz and Cullen, 1998;
Unutmaz et al., 1998; Berger et al., 1999). With the unique
exception of SIVrcm from red-capped mangabeys, which
uses CCR2B (Chen et al., 1998b), primary human and
simian immunodeficiency viruses (HIV and SIV, respec-
tively) frequently utilize the CC chemokine receptor CCR5
(R5) as entry cofactor (Alkhatib et al., 1996; Choe et al.,
1996; Deng et al., 1996; Doranz et al., 1996; Dragic et al.,
1996; Chen et al., 1997, 1998a; Hill et al., 1997; Kirchhoff
et al., 1997; Marcon et al., 1997). Some differences be-
tween the different groups of primate lentiviruses exist,
however, in the ability to use additional coreceptors.
CXCR4 (X4) is the second major coreceptor of HIV-1, the
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287main causative agent of AIDS (Feng et al., 1996). HIV-1
variants that efficiently use X4 evolve in about 50% of all
AIDS patients (Van’t Wout et al., 1998; Xiao et al., 1998).
The appearance of X4-tropic variants is associated with
a poor prognosis and might play an important role in
AIDS pathogenesis. A number of alternative coreceptors
that mediate entry or Env-mediated cell–cell fusion have
been described (reviewed by Unutmaz et al., 1998). How-
ever, efficient utilization of these alternative receptors is
rare and replication of HIV-1 in primary cells seems to be
mainly mediated by R5 or X4 (Zhang et al., 1998a,b, 1999,
2000). In comparison to HIV-1, the second type of human
immunodeficiency virus (HIV-2) is less restricted to CCR5
and CXCR4 and frequently uses additional coreceptors,
such as GPR15, STRL33, CCR1, CCR2b, CCR3, CCR8,
CCR9, ChemR23, US28, V28, APJ, RDC-1, and BLR1/
CXCR5 for entry into target cells (Bron et al., 1997; Deng
et al., 1997; Edinger et al., 1997, 1998; Sol et al., 1997;
Owen et al., 1998; Mo¨rner et al., 1999).
In contrast to both HIV-1 and HIV-2, even laboratory-
adapted strains of SIV derived from infected macaques
(SIVmac) use R5, and frequently the orphan receptors
GPR15 and STRL33, but rarely X4 for efficient entry (Chen
et al., 1997, 1998a; Hill et al., 1997; Kirchhoff et al., 1997;
Marcon et al., 1997). The exact role of these orphan
receptors in the pathogenesis of SIV remains to be clar-
ified but recent findings suggest that GPR15 and STRL33
usage, in addition to R5, is of limited relevance for SIV-
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288 MEISTER ET AL.mac replication in vivo (Po¨hlmann et al., 1999, 2000). It is
striking that SIVmac rarely uses X4, because (i) ma-
caque- and mangabey-derived X4 is fully functional for
HIV entry (Chen et al., 1998a; Marx and Chen, 1998); (ii)
X4-tropic SHIVs can replicate efficiently and induce im-
munodeficiency in infected macaques (Harouse et al.,
1999); and (iii) SIVmac is closely related to HIV-2, which
frequently utilizes X4, and both originate from naturally
infected sooty mangabeys (Gao et al., 1992).
Elucidation of biological differences between HIV and
SIV is important, because infection of rhesus macaques
with SIVmac represents the most commonly used animal
model for studies of AIDS pathogenesis and vaccine
development (Desrosiers and Ringler, 1989; Johnson and
Hirsch, 1992). For HIV-1 it has been well established that
isolates containing a V3 loop with a relatively low posi-
tive net charge (13 to 16) commonly utilize R5, whereas
isolates with a more basic V3 region (usually 17 to 19)
use X4 with high efficiency (DeJong et al., 1992; ; Shioda
et al., 1992; Choe et al., 1996; Cocchi et al., 1996; Bieniasz
et al., 1997; Hoffman et al., 1998). Also for HIV-2 it has
been shown that an increase in the net positive charge of
the V3 region allows efficient utilization of X4 (Isaka et al.,
1999). The V3 region is also a determinant of SIVmac cell
tropism (Kirchhoff et al., 1994), but the requirements for
efficient utilization of X4 are currently unknown. In the
present study, we investigated if a more basic V3 loop
region in SIVmac Env mediates a coreceptor switch from
R5 to X4. We demonstrate that additional basic residues
in the V3 loop of SIVmac affect coreceptor tropism and
infectivity, but do not allow efficient utilization of X4 for
entry or replication.
RESULTS
SIVmac239 (239wt) is a well-characterized molecular
clone that causes AIDS in infected rhesus macaques
(Kestler et al., 1990). It replicates well in rhesus periph-
eral blood mononuclear cells (rPBMC) and in immortal-
ized T-cell lines, but only poorly in rhesus macaque
FIG. 1. Amino acid substitutions in the SIVmac V3 region investigat
ositions corresponding to basic residues (shaded) and an acidic D res
lignment specify the amino acid position in the 239 Env. The number o
re given in the right panel.alveolar macrophages (Mori et al., 1992). SIVmac239
efficiently utilizes R5, GPR15, and human-derivedSTRL33, but not X4 as entry cofactor (Edinger et al., 1997;
Chen et al., 1997; Hill et al., 1997; Farzan et al., 1997;
Kirchhoff et al., 1997; Marcon et al., 1997; Po¨hlmann et al.,
2000). Alterations in the V3 loop region of 239wt Env
affect viral cell tropism (Kirchhoff et al., 1994). However,
changes that mediated efficient replication in macro-
phages mapped to different regions in Env (Mori et al.,
1992). The V3 loop of 239wt encompasses 34 amino
acids and has a net charge of 14, resembling that of
R5-tropic HIV-1 isolates. We introduced basic amino acid
residues at positions 10, 11, 18, 24, and 27 in the V3
region of 239wt gp120 (Fig. 1) to investigate if an in-
crease in basic charge affects SIV coreceptor tropism.
These substitutions were introduced at positions similar
to those that were previously shown to be associated
with efficient utilization of X4 by HIV-1 and HIV-2 strains
(Shioda et al., 1992; Choe et al., 1996; Cocchi et al., 1996;
Bieniasz et al., 1997; Isaka et al., 1999) and resulted in a
net charge between 15 and 110 (Fig. 1).
First, we investigated the expression levels of the
mutated glycoproteins in 293T cells transfected with pro-
viral 239wt constructs differing only in the env gene.
Western blot analysis revealed that most V3 Env variants
were efficiently expressed and processed (Fig. 2A, Table
1). A single amino acid substitution of L328R located
close to the tip of the loop, however, resulted in strongly
reduced gp120 and moderately reduced gp42 expres-
sion levels, compared to 239wt transfected cells (Fig. 2A,
lane 3). Notably, additional mutations of L320K-P321R
(KR) or P334K-D337K (KK) both individually or in combi-
nation restored efficient expression of 239Env carrying
the L328R substitution (Fig. 2A, lanes 5, 7, 8). The
amounts of the 239KR, 239KK, 239KRR, 239KRKK,
239RKK, and 239KRRKK gp120/160 proteins detected in
the cellular extracts were similar or only slightly reduced
compared to those detected in 239wt transfected cells
(Table 1). Thus, with the exception of L328R-Env, all
mutated Env proteins were efficiently expressed in trans-
fected 293T cells.
is study. Dashes indicate identity to the V3 sequence of SIVmac239.
oxed) in the wild-type V3 region are indicated. The numbers above the
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289DETERMINANTS OF SIV CORECEPTOR TROPISMtaining a normalized amount of p27 antigen was har-
vested from the supernatant of the transfected cells,
pelleted, and used for Western blot analysis. Compara-
ble amounts of p27, Nef, p55Gag, and p66Pol were de-
tected in all cell culture supernatants (Fig. 2B, Table 1).
No gp120 was found, however, in the supernatant of
293T cells transfected with the 239L328R construct, even
after long overexposure (Fig. 2B, bottom, lane 3). In
comparison, the gp42 levels were only about threefold
reduced relative to 239wt. The amount of gp120 detected
in the supernatant of 239KRKK-transfected cells was also
strongly reduced (Fig. 2B, lane 6), despite relatively nor-
mal expression levels in the transfected cells (Fig. 2A,
lane 6). In contrast, the gp120 levels were comparable to
239wt in the 239KR, 239KRR, and 239RKK virus stocks,
FIG. 2. Detection of viral proteins in 293T cells transfected with pro
Proteins in the cellular extracts (A) or in the cell-free culture supernata
or 5% (bottom) SDS–PAGE and detected by ECL immunoblot using po
derived from SIVmac p27 hybridoma cells (B, middle). Virus was harve
described under Materials and Methods. Similar results were obtaine
TABLE 1
Effect of Mutations in the SIVmac239 V3 Region
on Protein Expression Levels
Mutant
Cellular extracta Supernatanta
p27 Nef TM gp120 p27 Nef TM gp120
239KR 52 55 67 45 99 92 95 90
239L328R 104 88 24 4 107 111 34 0
239KK 93 88 85 55 96 103 125 52
239KRR 102 93 89 91 115 109 84 110
239KRKK 78 83 81 65 115 114 75 7
239RKK 73 84 90 76 109 107 88 130
239KRRKK 85 93 86 83 96 88 33 44
a Viral proteins were detected by ECL immunoblot in the cellular
xtract of transfected 293T cells or in the culture supernatant (Fig. 2).
ignals were analyzed as described under Materials and Methods.
xpression levels are given in percentage relative to the amounts of
39wt protein detected.and only slightly reduced in supernatant of cells trans-
fected with the proviral 239KK and 239KRRKK constructs
(Table 1).
A variety of indicator cells was infected with the 239wt
Env variants to evaluate the effect of basic residues in
the V3 loop on viral coreceptor tropism and infectivity. As
shown in Fig. 3, the 239KR variant entered efficiently into
MAGI-R5, U373-R5, and P4R5 cells, which coexpress
CD4 and CCR5, but not into GPR15-expressing MAGI
cells. Thus, substitution of L320K-P321R (KR) selectively
impaired utilization of GPR15. In agreement to absence
of detectable gp120 in the virus supernatant (Fig. 2B,
lane 3), the 239L328R variant was noninfectious. In con-
trast, the 239KK mutant, containing changes of P334K
and D337K in the C-terminal half of the V3 loop, consis-
tently infected all indicator cells with 239wt-like effi-
ciency. The 239KR and 239KK variants also entered with
239wt-like efficiency into sMAGI cells that express GPR1,
GPR15, and as-yet-unknown entry cofactors (S. Po¨hl-
mann and F. Kirchhoff, unpublished observations) (Fig.
3C). The 239KRR, 239RKK, and 239KRRKK variants
showed little if any infectivity, despite efficient Env ex-
pression level. The combined changes present in the
239KRKK variant greatly reduced viral infectivity, al-
though the L320K-P321R (KR) and P334K-D337K (KK) sub-
stitutions individually had little disruptive effects on R5
usage. Inefficient infection with the 239KRKK mutant is
consistent with the low amounts of gp120 detected in the
viral stocks (Fig. 2B, lane 6). Nonetheless, significant
entry into U373-R5 cells was observed (Fig. 3E), suggest-
ing that the residual KRKK-Env protein was able to me-
diate infection. Importantly, all functional SIVmac V3 vari-
IVmac239 constructs containing wild-type or mutated V3 sequences.
f transiently transfected 293T cells were separated through 10% (top)
era derived from SIV-infected rhesus macaques or an antigag serum
nd cell lysates were prepared and used for Western blot analysis as
independent experiment.viral S
nt (B) o
oled sants entered X4-expressing U373 cells much less effi-
ciently than R5-expressing U373 cells (Fig. 3F).
Eions performed with two different virus stocks. The average b-galactosidase
r .p.s., counts per second.
290 MEISTER ET AL.Coreceptor expression levels are highly important for
SIV and HIV entry (Kozak et al., 1997; Rucker et al., 1997;
dinger et al., 1998; Po¨hlmann et al., 1999; Sharron et al.,
2000). We infected transiently transfected 293T cells co-
expressing CD4 and a variety of G-protein coupled re-
ceptors (GPCRs) with 239wt variants carrying the lucif-
erase reporter gene to investigate the effect of the V3
changes on viral entry via a broad panel of GPCRs at
high expression levels. None of the SIVmac variants,
including 239wt, showed appreciable entry into cells
coexpressing human or rhesus-derived CD4 and
huCXCR4, rhCXCR4, rhCCR4, smCCR3, rhCCR3,
smCCR8, or rhCCR8 (hu, human; rh, rhesus; sm, sooty
mangabey; data not shown). Similarly, huAPJ was used
only very inefficiently as SIV entry cofactor (Fig. 4). Only
239wt could utilize rhGPR1 as entry cofactor, albeit with
about 10- to 20-fold lower efficiency than huSTRL33,
rhCCR5, or rhGPR15 (Fig. 4). The results obtained with
the CCR5- and GPR15-expressing 293T cells were simi-
lar to those obtained with the stable transfected indicator
cell lines shown in Fig. 3. The 239KK variant entered with
high efficiency, compared to the remaining V3 variants,
FIG. 3. Basic amino acid residues in the V3 loop affect SIVmac239
containing 50 ng p27 antigen. Cells were plated on 48-well dishes a
changed and b-galactosidase activities were measured 2 days later as
239wt (%). In F entry of 239wt into R5 expressing U373 cells is shown
isolates (not shown). Values were derived from six independent infect
eporter activities obtained for wild-type infected cells are indicated. cinfectivity. The indicated reporter cell lines were infected with virus stocks
nd infected the next day. After 4 h incubation, the cell culture medium was
described under Materials and Methods. Viral infectivity is shown relative to
for comparison. U373-X4 cells could readily be infected with X4-tropic HIVinto R5-, GPR15-, and STRL33-expressing cells. The
239KR mutant also utilized R5 and STRL33 but not GPR15FIG. 4. Entry of SIVmac239 V3 variants into transiently transfected
293T cells coexpressing CD4 and various GPCRs. 293T cells were
transfected with plasmids expressing human CD4 and the entry cofac-
tors indicated. At 1 day posttransfection, the cells were detached from
the plates, seeded in 48-well dishes, and infected in triplicate with
replication-competent SIV carrying the luciferase gene in place of the
nef gene. Virus stocks containing normalized amounts of p27 antigen
(100 ng) were used for infection. Luciferase activities in the cellular
extracts were measured at 3 days postinfection. Results were con-
firmed in an independent experiment. No significant entry was ob-
served in cells cotransfected with plasmids expressing CD4 and
huCXCR4, rhCXCR4, smCCR3, rhCCR3, smCCR8, or rhCCR8.
ssays
pende
291DETERMINANTS OF SIV CORECEPTOR TROPISMfor efficient entry. Of the remaining five SIVmac239 V3
variants, only 239KRKK showed appreciable levels of
entry into R5-expressing cells (Fig. 4). Thus, all forms
containing the L328R changes close to the tip of the loop
were defective for infectivity.
Next, we investigated the effect of the V3 mutations on
239wt replication in PM1 cells that express both R5 and
X4, and in CEMx174 cells that express GPR15 and X4 but
not CCR5. Overall, the replication data correlated with
the infectivity results shown in Figs. 3 and 4. Only the
239KR and 239KK variants that entered efficiently into
R5-expressing cells replicated above background levels
in PM1 cells (Fig. 5). However, viral replication was less
efficient and delayed compared to 239wt. In agreement
with the grossly impaired infectivity for GPR15-express-
ing MAGI or 293T cells, the 239KR variant did not repli-
cate in CEMx174 cells (Fig. 5). In contrast, the 239KK
variant was infectious for CEMx174 cells, although the
replication kinetics were significantly delayed compared
to 239wt. None of the remaining V3 mutants, 239L328K,
239KRR, 239KRKK, 239RKK, and 239KRRKK were replica-
FIG. 5. Replication of SIVmac239 V3 variants in PM1 and CEMx174
transiently transfected 293T cells. Virus production was monitored by a
indicated days postinfection. Similar results were obtained in two inde
FIG. 6. Replication of SIVmac239 V3 variants in human and rhesus
Infections, cell culture, and quantitation of infectivity were performed as desc
three independent experiments using different virus stocks and PBMC from dtion-competent in PM1 or CEMx174 cells, even when
very high viral doses (up to 200 ng p27 antigen) were
used for infection (Fig. 5, and data not shown). Further-
more, no replication was observed in Jurkat cells, which
express CD4 and X4 and allow efficient propagation of
X4-tropic HIV-1 isolates (data not shown). These results
suggest that additional basic amino acid residues in the
V3 region have a differential effect on 239wt coreceptor
tropism and infectivity but, unlike HIV-1 and HIV-2 Env, do
not allow utilization of X4 for efficient entry or replication.
To assess the infectivity of the various 239wt mutants
for primary cells, human and rhesus macaque PBMC
were isolated from whole blood and infected with the
different SIVmac239 V3 variants. SIVmac 239wt repli-
cated efficiently in both human- and rhesus-derived cells
(Fig. 6). In agreement with the relatively efficient utiliza-
tion of CCR5 (Figs. 3 and 4), the 239KR and 239KK
variants replicated in the PBMC cultures, albeit with
delayed kinetics compared to 239wt. Concordant with
the inefficient infection of the cell lines, and the inability
to replicate in PM1 or CEMx174 cells, none of the re-
The cells were infected with 5 ng p27 containing virus derived from
of reverse transcriptase (RT) activity in the culture supernatants at the
nt experiments. PSL, photograph stimulated light emission.
. The cells were infected with virus containing 5 ng of p27 antigen.cells.PBMC
ribed under Materials and Methods. Similar results were obtained in
ifferent donors.
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292 MEISTER ET AL.maining V3 variants showed significant levels of replica-
tion. Thus, replication in human and rhesus PBMC cor-
related with the ability of the SIVmac V3 variants to utilize
CCR5 as entry cofactor.
In the final set of experiments we investigated the
ability of the SIVmac239 V3 variants to replicate in PBMC
derived from a homozygous D32/D32 donor. Similar to
the results obtained with PBMC derived from normal
donors (Fig. 6), the 239KK variant replicated efficiently,
but with delayed kinetics compared to 239wt, in D32/D32
PBMC (Fig. 7). In contrast, the 239KR variant, which
utilized R5 but not GPR15 for efficient entry, did not show
significant levels of replication, even when high doses of
virus were used for infection (Fig. 7). These findings
resemble the results obtained after infection of CEMx174
cells (Fig. 5), which express GPR15 but not R5, and
suggest that the orphan receptor GPR15 allows efficient
replication of SIVmac in human PBMC.
DISCUSSION
In this study, we show that an increase in the net
positive charge of the SIVmac239 V3 region was not
associated with an efficient utilization of X4 as entry
cofactor. It has been shown previously that a few amino
acid changes in the C-terminal half of the HIV-2 V3 loop
determine coreceptor usage of R5 and X4 (Isaka et al.,
1999). The SIVmac V3 variants analyzed in our study
contain basic residues at positions in the V3 region
which are similar to those found to be associated with
efficient utilization of X4 by HIV-2. It remains possible that
other changes in the V3 region of SIVmac might shift the
coreceptor usage. Nonetheless, our results suggest that
the requirements for effective coreceptor usage of X4
might differ between SIVmac and HIV-1 or HIV-2 Env
proteins. A relatively high number of changes in SIVmac
Env might be required for a coreceptor switch from R5 to
X4. Thus, the probability that such SIVmac variants
FIG. 7. Replication of SIVmac239 V3 variants in PBMC derived from a
nd 100 ng of p27 antigen as indicated in the figure.emerge in vivo could be low, compared to HIV infection of
uman individuals.
C
tRecently, it has been described that some primary SIV
solates from sooty mangabeys (SIVsm) utilize X4 as a
oreceptor for entry (Owen et al., 2000). In contrast to
IV-2 strains, however, all SIVsm isolates analyzed in
his study entered X4-expressing indicator cell lines with
uch lower efficiency than R5-expressing cells. Further-
ore, X4-utilizing SIV strains were frequently blocked
ess effectively than HIV isolates by X4 antagonists
Owen et al., 2000). CXCR4 was not described as a
unctional coreceptor for primary or laboratory-adapted
IVmac or SIVsm strains in a number of previous studies
Chen et al., 1997; Edinger et al., 1997; Hill et al., 1997;
irchhoff et al., 1997; Marcon et al., 1997; Schols and De
lerk, 1998). We found that virus reisolated from 20 239wt
nfected macaques at late stages of infection was unable
o utilize X4 for replication (S. Po¨hlmann, C. Stahl-Hennig,
nd F. Kirchhoff, unpublished observations). This is con-
istent with reports that SIV variants, which evolve during
he course of infection, show increased replicative ca-
acity and cytopathic properties but not a switch in
oreceptor usage from R5 to X4 (Rudensy et al., 1998;
imata et al., 1999). In agreement with the results of the
resent study, these findings suggest that the SIVmac
nv might interact with specific coreceptors in a manner
omewhat different from the HIV-1 and HIV-2 Env pro-
eins.
Changes of L320K and P321R in the N-terminal half of
he SIVmac V3 loop severely reduced utilization of GPR15
or entry and replication but had much less effect on
oreceptor usage of CCR5 and STRL33. In an early study
n the function of SIVmac V3 loop, it has been shown that
change of P321S impairs viral replication in CEMx174
ell, which express GPR15, but not in R5-expressing
acrophages or rPBMCs (Kirchhoff et al., 1994). Thus,
mino acid residues at positions 320 and 321 in SIVmac
nv are important for the coreceptor usage of GPR15 but
ess critical for the interaction with CCR5 and STRL33.
32 donor. Infections were performed with virus stock containing 1, 10,hanges of P334K and D337K in the C-terminal half of
he SIVmac V3 region did not allow utilization of X4 or
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293DETERMINANTS OF SIV CORECEPTOR TROPISMdisrupt coreceptor usage of R5. Similarly, the introduction
of positively charged amino acids at positions 333Q3 K
nd 336N 3 K of the Env protein of the M-tropic SIV-
ac316 strain did not impair efficient viral replication in
hesus alveolar macrophages (Kirchhoff et al., 1994). In
comparison, it has been described that the C-terminal
half of the HIV-2 V3 region determines the coreceptor
specificity for X4 and R5 (Isaka et al., 1999). In the case
of SIVmac Env, changes in the C-terminal half of the V3
region frequently have little effect on coreceptor tropism.
We found, however, that even highly homologous amino
acid substitutions in the N-terminal half of the SIVmac V3
loop have differential effects on R5 and GPR15 corecep-
tor usage (Po¨hlmann et al., 1999; S. Po¨hlmann and F.
Kirchhoff, unpublished observations). Thus, residues lo-
cated between the potential N-linked glycosylation site
and the conserved tip of the SIVmac V3 loop seem to be
important for the interaction with specific coreceptors,
like GPR15.
An unexpected finding of our study was that a single
L328R change located at the crown of the V3 loop had
differential effects on Env expression levels, depending
on the presence or absence of other amino acid substi-
tutions in this region. When the L328R change was in-
troduced into the 239wt Env, it resulted in severely re-
duced gp120 expression levels. It had only little effect on
Env expression levels, however, when additional basic
amino acid residues were introduced elsewhere in the
SIVmac V3 loop. Strikingly, the L328R substitution
seemed to have restorative effects on gp120 virion as-
sociation when it was present in the 239KRKK back-
ground. All SIVmac239 variants containing the L328R
substitution were impaired in replication and infectivity.
This is consistent with previous observations with both
HIV-1 and SIVmac showing that the conserved tip of the
V3 loop is critical for infection (Berger et al., 1992; Page
et al., 1992; Kirchhoff et al., 1994).
In conclusion, we show that changes in the SIVmac V3
region can affect gp120 expression levels as well as viral
infectivity and coreceptor tropism. Amino acid residues
in the N-terminal half of the loop are critical for the ability
to utilize GPR15 as entry cofactors. The exact require-
ments for the interaction of SIVmac Env with CXCR4 need
further clarification. The results suggest, however, that
the SIVmac and HIV Env proteins interact with X4 in a
somewhat different manner and that basic amino acid
residues in the SIVmac V3 region are insufficient to
mediate a coreceptor switch from R5 to X4.
MATERIALS AND METHODS
Mutants
The SIVmac239 V3 mutants were generated by splice
overlap extension PCR essentially as described previ-
ously (Po¨hlmann et al., 1999). Briefly, the 239wt env re-
gion was amplified using p5outV3 (59-GAGTCTTGTGA-CAAACA-39) and p3outV3 (59-TCCTCTGCAATTTGTCCA-
39) as outer primers, and three pairs of inner primers: (i)
L320K-P321R: pK320R53 (59-GACAGTTAAACGAGTCAC-
CATTATG-39) and pK320R35 (59-GAC-TCGTTGAACTGTC
TTATTTCCTG-39); (ii) L328R: pR328R53 (59-GTCTGGAC-
GAGTT-TTCCACTCACAA-39) and pR328R35 (59-AAA-
CTCGTCCAGACATAATGGTG-39); and (iii) P334K-D337K:
pK334K53 (59-AAAAGATCAATAAGAGGCCAAAGCAGGC-
AT-39) and pK334K35 (59-CTTATTGATCTTTTGTGAGTG-
GAAAAC-39). Changes compared to the 239wt sequence
are shown in bold letters. PCR products were gel puri-
fied, mixed, and subjected to a second round of PCR with
the outer primers p5outV3 and p3outV3. The unique XhoI
and MroI restriction sites flanking the V3 region were
used for cloning into a modified full-length 239wt provi-
rus as described previously (Po¨hlmann et al., 1999). The
239KR, 239L328R, and 239KK variants were used as
templates for additional rounds of SOE-PCR with the
primers listed above to generate the 239KRR, 239KRKK,
239RKK, and 239KRRKK mutants (Fig. 1). All PCR-derived
inserts were sequenced to ensure that only the intended
changes were present. Using standard cloning tech-
niques, the deleted env gene of pBR239DenvLuc (Kirch-
hoff et al., 1997) was replaced with the intact 239wt and
V3 mutant env genes to generate replication-competent
luciferase reporter viruses.
Cells
CEMx174, PM1, and Jurkat cells were maintained in
RPMI 1640 medium supplemented with 10% FCS. sMAGI
cells (Chakerian et al., 1997), MAGI-CCR5, MAGI-GPR15,
and 293T cells as well as U373-MAGI-CCR5E and U373-
MAGI-CXCR4CEM cells (Vodicka et al., 1997) were grown
in DMEM medium supplemented with 10% FCS and
antibiotics. Rhesus and human peripheral blood mono-
nuclear cells were isolated using lymphocyte separation
medium (Organon Teknika Corporation, Durham, NC)
stimulated for 3 days with 2 mg/ml phytohemagglutinin
nd cultured in RPMI 1640 medium with 20% FCS and
00 U/ml IL-2. Supernatants were collected at 3 or 4 day
ntervals and virus production was measured by reverse
ranscriptase assay as described (Potts, 1990).
irus stocks
For the generation of virus stocks, 293T cells were
ransfected by the calcium phosphate method with 5 mg
of the full-length proviral SIVmac239 constructs differing
only in the env gene as described previously (Deng et al.,
1996; Po¨hlmann et al., 1999). After overnight incubation,
the medium was changed and virus was harvested 24 h
later. Viral stocks were aliquoted and frozen at 280°C.
The p27 antigen concentrations of viral stocks were
quantitated with an SIV p27 antigen capture ELISA ob-
tained through the National Institutes of Health AIDS
Research and Reference Reagent Program.
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MAGI, U373, and P4R5 reporter cell lines were seeded
in 48-well dishes and infected with viral stocks contain-
ing 50 ng p27 antigen in a total volume of 0.5 ml medium.
After 4 h incubation the cell culture medium was
changed. The cells were lysed and the b-galactosidase
ctivities were measured using a commercially available
it (Tropix) 2 to 3 days after infection. To determine entry
n 293T cells that overexpress CD4 and the various
oreceptors, 293T cells were transiently cotransfected
ith 5 mg (each) of the CD4 and the various coreceptor
expression vectors. pBabe-puro vectors expressing hu-
man and rhesus macaque CCR5 were provided by
Nathaniel Landau and Preston Marx through the AIDS
Research and Reference Program, Division of AIDS,
NIAID, NIH. Expression vectors for human GPR15 and
STRL33 were kindly provided by Dan Littman (Skirball
Institute for Molecular Medicine, New York, NY). Vectors
expressing rhesus macaque GPR15 and STRL33 were
generated as described previously (Po¨hlmann et al.,
2000). After overnight incubation, the medium was
changed and the cells were seeded in 48-well dishes.
The following day cells were infected with luciferase-
reporterviruses differing only in the V3 coding region of
the env gene. Virus stocks containing 100 ng p27 antigen
were used for infection. At 3 days after infection, cells
were lysed and the luciferase activities in 20-ml cell
ysates were determined using a commercially available
it (Promega).
estern blot analysis
293T cells were transfected with 10 mg DNA of the
proviral constructs. After overnight incubation, the me-
dium was replaced by fresh DMEM. At 48 h after trans-
fection, the viral supernatant was removed and the cells
were harvested and lysed with lysis buffer (0.5% Nonidet-
P40, 0.15 M NaCl, and 50 mM HEPES buffer [pH 7.5])
containing 10 mM NaF and 1 mM PMSF (Sigma Chem-
icals, St. Louis, MO). Virus stocks containing 460 ng p27
antigen in a total volume of 1 ml medium were used for
the detection of viral antigens in the cell-free culture
supernatants. Virions were pelleted in a microcentrifuge
(14,000 rpm, 1 h, 4°C), washed with PBS, and resus-
pended in 15 ml lysis buffer. Viral proteins were sepa-
ated through 5 or 10% SDS–PAGE and detected by ECL
mmunoblot using pooled sera from six SIVmac-infected
hesus macaques. For detection of p27 core protein, an
ntigag serum derived from SIVmac p27 hybridoma cells
55–2F12) was used (Higgins et al., 1992). For ECL de-
ection, horseradish peroxidase-conjugated secondary
ntibodies were used. Signals were analyzed using the
elDoc system (Bio-Rad), following the protocols pro-
ided by the manufacturer.ACKNOWLEDGMENTS
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